121
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Pharmacological Treatment of Fibromyalgia: Is The Glass Half Empty or Half Full?

, &
Pages 5-10 | Received 12 Sep 2016, Accepted 22 Sep 2016, Published online: 10 Oct 2016
 

Financial & competing interests disclosure

This commentary has not received any financial support. F Rico-Villademoros has served as freelance consultant for Almirall, AstraZeneca, Eli Lilly, GSK, Lundbeck, Pfizer, Roche and Sanofi-Aventis. The authors have no other relevant affiliations or financial involvement with any organization with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

The commentary has been reviewed by a professional English language-editing company (American Journal Experts); this service has been funded by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.